Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesOphthalmology/OptometryCigna Corneal Remodeling Coverage Update | OpenPay…
    Ask Trek AI about this page
    ModifiedCignaPolicy 0141

    Corneal Remodeling

    Customize your policy alerts

    Sign up for Cigna Policy 0141 alerts

    Get alerted when Policy 0141 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage and medical-necessity determinations for corneal remodeling procedures used to correct refractive errors and treat selected corneal conditions. Coverage depends on the applicable benefit plan and, where specified, fulfillment of procedure-specific clinical criteria.

    Policy Summary
    PayerCigna
    PolicyCorneal Remodeling
    Policy CodePolicy 0141
    Change TypeModified
    Effective DateNov 15, 2026
    Next Review DateNov 15, 2027
    Key ActionSubmit the service using the most appropriate codes effective on the submission date and include applicable covered procedure and diagnosis codes.
    SourceLink
    POLICY UPDATE CHANGES

    Added a policy statement for anterior lamellar keratoplasty.

    Revised the policy statement for corneal relaxing incisions.

    Removed hexagonal keratotomy, laser epithelial keratomileusis, laser thermokeratoplasty, minimally invasive radial keratotomy, penetrating keratoplasty, and scleral expansion surgery from the policy statements.

    Removed keratophakia and orthokeratology from the policy statement.

    Added corneal allogenic intrastromal ring segments and corneal tissue addition keratoplasty to the policy statement.

    Removed policy statements for corneal collagen cross-linking and corneal wedge resection.

    Removed laser in situ keratomileusis, photorefractive keratectomy, and radial keratotomy from the policy statement.

    1Procedure statement added in the 2026 annual review
    1Procedure statement revised in the 2026 annual review

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    6Procedure statements removed in the 2026 annual review
    ≥3.00 DMinimum astigmatism for covered corneal relaxing incision
    Age ≥21Minimum age for covered intrastromal corneal ring segments
    3Procedure categories identified as experimental, investigational, or unproven

    Covered, Excluded, and Investigational Procedures

    Anterior Lamellar Keratoplasty

    Covered when BOTH of the following criteria are met:

    BOTH of the following

    • Healthy corneal endothelium is present.
    • ANY of the following indications

      • Corneal ectatic disorder, such as keratoconus or pellucid marginal degeneration.
      • Corneal edema, opacification, scarring, or thinning.
      • Corneal stromal dystrophy, such as lattice or granular dystrophy, or degeneration.
      • Corneal ulceration.
      • Infectious keratitis unresponsive to antimicrobial therapy.

    Corneal Relaxing Incisions

    Covered when ALL of the following criteria are met:

    ALL of the following

    • Astigmatism is due to previous cataract or corneal transplant surgery.
    • Degree of astigmatism is 3.00 diopters (D) or greater.≥ 3.00 D
    • Individual is intolerant of glasses or contact lenses.

    Intrastromal Corneal Ring Segments

    Covered when ALL of the following criteria are met:

    ALL of the following

    • INTACS are provided in accordance with the FDA Humanitarian Device Exemption specifications.
    • Treatment is for myopia and/or astigmatism in an individual with keratoconus.
    • Progressive deterioration in vision prevents adequate daily functional vision with contact lenses or spectacles.
    • Individual is 21 years of age or older.≥ 21 years
    • Central corneas are clear.

    Anterior Lamellar Keratoplasty — Supported Indications

    Anterior lamellar keratoplasty, including DALK, is supported when the pathology is confined to the anterior cornea and the endothelium is healthy or uninvolved.

    Supported clinical criteria

    • Healthy or intact Descemet membrane and corneal endothelium.
    • ONE or more supported indications

      • Corneal ectatic disorder, including keratoconus, keratoglobus, or pellucid marginal degeneration.
      • Corneal edema, opacity, scarring, or thinning.
      • Corneal stromal dystrophy or degeneration.
      • Corneal ulceration, including descemetocele.

    Corneal Relaxing Incisions — Supported Use

    Evidence generally supports corneal relaxing incisions for high-degree, surgically induced astigmatism after cataract or corneal transplant surgery.

    Supported clinical criteria

    • Astigmatism is iatrogenic or surgically induced, typically following cataract removal or corneal transplant surgery.
    • Astigmatism is high degree, generally 3.00 D or greater.≥ 3.00 D
    • The individual is intolerant of glasses or contact lenses.
    • Treatment is performed using an appropriate corneal or limbal relaxing incision technique.

    Intrastromal Corneal Ring Segments — Qualifying Use

    Intrastromal corneal ring segments are supported for appropriately selected individuals with keratoconus or corneal ectasia when FDA HDE criteria are satisfied.

    Qualifying keratoconus criteria

    • Progressive deterioration in vision prevents adequate daily functional vision with contact lenses or spectacles.
    • Individual is 21 years of age or older.≥ 21 years
    • Central cornea is clear.
    • Corneal thickness at the proposed incision site is at least 450 microns.≥ 450 microns

    Conductive Keratoplasty — FDA Parameters and Evidence

    The ViewPoint CK System has FDA-labeled parameters, but coverage is not established solely by FDA approval and current clinical evidence is insufficient.

    FDA-labeled parameters described in the source

    • Temporary induction of myopia in the nondominant eye to improve near vision in presbyopic hyperopes or emmetropes.
    • Age 40 years or older.≥ 40 years
    • Refraction stable for the prior 12 months, with less than 0.50 D change in spherical and cylindrical components.< 0.50 D change
    • Cycloplegic refractive cylinder is less than 0.75 D.< 0.75 D

    CAIRS — Investigational Status

    CAIRS is considered investigational because long-term safety and efficacy have not been established.

    Evidence limitations

    • Insufficient published, peer-reviewed evidence supports the long-term safety and efficacy of CAIRS for keratoconus or any other condition.
    • Available evidence consists primarily of case reports and small prospective or retrospective case series with varied methods and short-term follow-up.
    • Long-term outcomes, durability, appropriate patient-selection criteria, and comparative effectiveness remain uncertain.
    • Formal professional-society guidance supporting CAIRS is lacking; the AAO states that long-term results are awaited.

    Corneal Inlays — Investigational Status

    Corneal inlays are considered investigational for any indication.

    Investigational status

    • Peer-reviewed evidence is primarily from nonrandomized single-arm trials, case reports, and case series, often with small populations and six months to four years of follow-up.
    • Reported adverse events include cataract progression, loss of visual acuity, and device explantation.
    • Formal professional-society guidance or support is lacking; the AAO describes corneal inlays for presbyopia as an area of active investigation.
    • FDA approval or historical device authorization does not establish coverage.

    CTAK — Investigational Status

    CTAK is considered investigational because evidence is insufficient to establish safety, efficacy, comparative effectiveness, or durable long-term benefit.

    Evidence limitations

    • Published evidence for CTAK in keratoconus, corneal ectasia, presbyopia, or other conditions is insufficient to support safety and efficacy.
    • Evidence consists primarily of small case series and uncontrolled, single-arm trials with short-term follow-up.
    • Comparative effectiveness against standard techniques and therapies, and durable net health benefits, are unknown.
    • Available studies have limitations including nonrandomized designs, lack of control groups, small samples, loss to follow-up, and reported adverse events or explantations.
    • Allotex Transform corneal implants are not approved or cleared by the FDA for use in the United States.

    Conductive Keratoplasty — Insufficient Evidence

    Conductive keratoplasty is considered investigational or unproven because evidence is insufficient for presbyopia or other refractive errors.

    Insufficient-evidence findings

    • Peer-reviewed evidence is insufficient to support effectiveness for presbyopia or other refractive errors.
    • Studies are primarily small case series with short follow-up, and refractive stability has not been meaningfully established.
    • Professional-society guidance contains limited references and no strong recommendation supporting current clinical use.
    • The AAO notes disadvantages including early overcorrection, regression, and induced astigmatism, and reports that CK is not frequently used today.

    Anterior lamellar keratoplasty is not medically necessary when performed solely for the elective treatment of refractive errors.

    Corneal relaxing incision is not medically necessary for non-surgically induced astigmatism or any other indication outside correction of qualifying surgically induced astigmatism.

    Intrastromal corneal ring segments are not medically necessary for indications other than the specified FDA HDE-based treatment of keratoconus.

    Automated lamellar keratoplasty and conductive keratoplasty are not medically necessary when performed solely for the elective treatment of refractive errors.

    Anterior lamellar keratoplasty is generally not supported for corneal pathologies affecting the endothelium, including bullous keratopathy and Fuchs' endothelial dystrophy, or when performed solely for elective astigmatism or other refractive errors.

    Limbal relaxing incisions are generally not clinically indicated for pre-existing, nonsurgically induced astigmatism; support is primarily for iatrogenic astigmatism following medically indicated ocular surgery.

    Intrastromal corneal ring segments are not medically indicated for mild myopia. Use for post-LASIK corneal ectasia remains off-label, is not an FDA-approved INTACS indication, and has uncertain long-term efficacy.

    Automated lamellar keratoplasty is unsupported for treatment of all refractive errors. The AAO has reported only fair predictability, multiple potential complications, and that ALK has been largely abandoned with the advent of LASIK.

    CAIRS is investigational for any indication because long-term safety and efficacy remain insufficiently established. Available evidence is limited primarily to small, uncontrolled studies with short-term follow-up, and formal professional-society support is lacking.

    The FDA issued a Class 1 device recall for the Raindrop Near Vision Inlay in March 2019 because of increased risk of corneal haze. The device is not currently commercially available.

    The Presbia Flexivue Microlens has a CE Mark for the European Economic Area but is not FDA-approved and is not commercially available in the United States.

    Allotex Transform corneal implants are not approved or cleared by the FDA for use in the United States.

    Historical elective refractive procedures identified as no longer in common use include hexagonal keratotomy, LASEK, laser thermokeratoplasty, minimally invasive radial keratotomy, and scleral expansion surgery. These procedures are included for informational purposes and are not supported as covered services under this policy.

    Anterior lamellar keratoplasty performed solely for elective refractive treatment is not medically necessary.

    Corneal relaxing incisions are excluded when used for non-surgically induced astigmatism or other indications that do not meet the qualifying surgical-history, severity, and lens-intolerance criteria.

    Intrastromal corneal ring segments are excluded for indications outside the specified qualifying keratoconus criteria.

    Automated lamellar keratoplasty and conductive keratoplasty are excluded when performed solely for elective refractive treatment.

    Intrastromal corneal ring segments are not medically indicated for mild myopia.

    Limbal relaxing incisions are generally not clinically indicated for pre-existing, nonsurgically induced astigmatism.

    Covered and Noncovered Coding

    Medically Necessary: Anterior Lamellar KeratoplastyCPTCovered
    65710Keratoplasty (corneal transplant); anterior lamellar
    Medically Necessary: Corneal Relaxing IncisionsCPTCovered
    65772Corneal relaxing incision for correction of surgically induced astigmatism
    66999Unlisted procedure, anterior segment of eye
    Medically Necessary: Intrastromal Corneal Ring SegmentsCPTCovered
    65785Implantation of intrastromal corneal ring segments
    Not Medically Necessary: Elective Treatment of Refractive ErrorsCPTNot Covered
    65760Keratomileusis
    66999Unlisted procedure, anterior segment of eye
    Experimental/Investigational/UnprovenCPTExperimental
    65710Keratoplasty (corneal transplant); anterior lamellar
    65785Implantation of intrastromal corneal ring segments
    66999Unlisted procedure, anterior segment of eye
    INTACS Prescription Inserts device identifiersmixed
    H040002INTACS® Prescription Inserts identifier
    LQEFDA product code for INTACS® Prescription Inserts
    ViewPoint CK System device identifiersmixed
    P010018ViewPoint™ CK System identifier
    MWDFDA product code for the ViewPoint™ CK System
    Corneal Relaxing Incision Threshold
    Minimum astigmatism3.00 diopters (D) or greater
    IndicationCorrection of surgically induced astigmatism with a corneal relaxing incision, including limbal relaxing incision
    Cause of astigmatismDue to previous cataract or corneal transplant surgery
    Intrastromal Corneal Ring Segment Age
    Minimum age21 years of age or older
    Qualifying condition

    Provider and Billing Guidance

    Billing Rule

    Use Current Covered Codes

    Use the most appropriate covered procedure and diagnosis codes that are effective on the date of submission. Code availability may change through AMA and CMS updates, and deleted or not-yet-effective codes may not be eligible for reimbursement.

    Denial Risk

    Elective Refractive-Error Treatment Not Covered

    Anterior lamellar keratoplasty (CPT 65710) is not medically necessary when performed solely for elective treatment of refractive errors.

    Denial Risk

    Clinical Background

    The cornea is a major refractive structure. Abnormalities in its shape, clarity, or thickness can cause refractive error and visual disturbance. Corneal ectasia, including keratoconus, may involve progressive thinning and conical deformation that produce irregular astigmatism, myopia, and visual loss. Treatment may range from spectacles and contact lenses to intrastromal ring segments or corneal transplantation, depending on disease severity and progression.

    Terms and Procedure Definitions

    Keratoconus
    ConditionAn eye condition in which the cornea becomes thin
    Shape changeThe cornea bulges into a cone shape
    Possible effectsBlurred vision and increased sensitivity to light and glare
    Keratoplasty
    Procedure typeA corneal transplant procedure
    Tissue removedDamaged cornea
    Tissue replacementHealthy donor corneal tissue
    Policy Summary
    PayerCigna
    PolicyCorneal Remodeling
    Policy CodePolicy 0141
    Change TypeModified
    Effective DateNov 15, 2026
    Next Review DateNov 15, 2027
    Key ActionSubmit the service using the most appropriate codes effective on the submission date and include applicable covered procedure and diagnosis codes.
    SourceLink
    On This Page
    Covered, Excluded, and Investigational ProceduresCovered and Noncovered CodingProvider and Billing GuidanceClinical BackgroundTerms and Procedure Definitions
    Corneal thickness at the proposed incision site is 450 microns or greater.≥ 450 microns
  1. Corneal transplantation is the only other remaining option for improving functional vision.
  2. Infectious keratitis refractory to medical or antimicrobial treatment.
  3. Corneal transplantation is the only remaining option to improve functional vision.
  4. INTACS prescription inserts are used in accordance with the FDA HDE specifications.
  5. Successful preoperative monovision trial or history of monovision wear.
  6. Despite the FDA-labeled parameters, peer-reviewed evidence is insufficient to support CK effectiveness for presbyopia or other refractive errors; available studies are small, largely case series, and have limited follow-up.
    Myopia and/or astigmatism in an individual with keratoconus
    Device requirementINTACS are provided in accordance with the FDA Humanitarian Device Exemption specifications
    Intrastromal Corneal Ring Segment Thickness
    Minimum corneal thickness450 microns or greater at the proposed incision site
    Corneal clarityClear central corneas
    Remaining treatment optionCorneal transplantation is the only other remaining option for improving functional vision
    High-Degree Corneal Astigmatism
    High-degree threshold≥ 3.00 D
    ProcedureArcuate keratotomy uses transverse or arcuate incisions in the paracentral cornea
    Intended effectChanges corneal curvature to reduce or eliminate high-degree corneal astigmatism
    FDA INTACS Myopia Range
    FDA INTACS myopia range-1.0 to -3.0 D
    Age criterionAdults age 21 or older
    Astigmatism criterion≤ 1.0 D of astigmatism
    FDA INTACS Astigmatism Limit
    FDA INTACS astigmatism limit≤ 1.0 D
    Myopia range-1.0 to -3.0 D
    Refraction requirementStability of refraction
    INTACS Keratoconus Thickness
    Minimum corneal thickness≥450 microns at the proposed incision site
    Age criterion21 years of age or older
    Corneal clarityClear central corneas
    AAO ICRS Thickness
    AAO minimum thickness≥400 microns
    Central corneaClear central cornea
    UseICRS may be used in selected eyes with corneal ectasia or keratoconus
    AAO Moderate Keratoconus
    AAO moderate keratoconus range<58.0 D
    Expected benefitMay improve corneal shape and visual function
    Disease progressionICRS do not alter the underlying progression of ectatic disease
    Conductive Keratoplasty Age
    Minimum patient age≥40 years
    FDA indicationTemporary induction of myopia to improve near vision in the non-dominant eye of presbyopic hyperopes or presbyopic emmetropes
    Monovision requirementSuccessful preoperative trial of monovision or history of monovision wear
    Conductive Keratoplasty Refractive Stability
    Refractive stabilityChange <0.50 D in spherical and cylindrical components during the prior 12 months
    MeasurementStability is demonstrated by the manifest refraction
    Time periodPrior 12 months
    Conductive Keratoplasty Cylinder
    Cycloplegic refractive cylinder<0.75 D
    DeviceViewPoint CK System
    FDA indication contextTemporary induction of myopia to improve near vision in the non-dominant eye

    Corneal Relaxing Incision Criteria

    Corneal relaxing incision, including limbal relaxing incision (CPT 65772 or 66999), is medically necessary only when all criteria are met: astigmatism resulted from prior cataract or corneal transplant surgery, is at least 3.00 diopters, and the individual is intolerant of glasses or contact lenses. It is not medically necessary for any other indication, including nonsurgically induced or pre-existing astigmatism.

    • Document the prior cataract or corneal transplant surgery.
    • Document astigmatism of at least 3.00 D and intolerance of glasses or contact lenses.
    • Do not submit for nonsurgically induced astigmatism.
    Denial Risk

    Ring-Segment Indication Must Qualify

    Intrastromal corneal ring segments (CPT 65785) are not medically necessary for indications other than the specified INTACS treatment of qualifying keratoconus.

    • Coverage is limited to the policy criteria, including FDA Humanitarian Device Exemption specifications, progressive functional-vision deterioration, age 21 or older, clear central corneas, corneal thickness of at least 450 microns, and corneal transplantation as the only remaining option to improve functional vision.
    • Do not submit for mild myopia or post-LASIK ectasia.
    Denial Risk

    Elective Refractive Procedures Not Covered

    Automated lamellar keratoplasty (ALK; CPT 65760) and conductive keratoplasty (CPT 66999) are not medically necessary when performed solely for elective treatment of refractive errors.

    • ALK is unsupported for treatment of all refractive errors.
    • Conductive keratoplasty is not supported for elective treatment of presbyopia or other refractive errors.
    Denial Risk

    Experimental or Unproven Procedures

    Corneal allogenic intrastromal ring segments (CAIRS; CPT 65785), corneal inlays (CPT 66999), and corneal tissue addition keratoplasty (CTAK; CPT 65710) are considered experimental, investigational, or unproven for any indication.

    • CAIRS lacks sufficient peer-reviewed evidence for long-term safety and efficacy.
    • Corneal inlays and CTAK are also classified as experimental, investigational, or unproven.
    Denial Risk

    Covered Codes Required

    Claims must include covered procedure and/or diagnosis code(s) under the applicable policy. Claims submitted without covered code(s) will be denied as not covered.

    • Verify that submitted codes are covered and effective on the date of service or submission, as applicable.
    • Services billed for conditions or diagnoses not covered under the policy are not reimbursable.
    Denial Risk

    Anterior Lamellar Keratoplasty Limitations

    Anterior lamellar keratoplasty is generally not supported for corneal pathologies affecting the endothelium, such as bullous keratopathy or Fuchs' endothelial dystrophy, and is not medically necessary when performed solely for elective treatment of astigmatism or other refractive errors.

    • Confirm healthy corneal endothelium when requesting coverage for anterior lamellar keratoplasty.
    • Submit the procedure for a covered indication under the applicable policy criteria.
    Denial Risk

    Nonsurgical Astigmatism Not Covered

    Limbal relaxing incisions and other corneal relaxing incisions are not medically necessary for nonsurgically induced or pre-existing astigmatism. Coverage is limited to qualifying surgically induced astigmatism following cataract or corneal transplant surgery, with astigmatism of at least 3.00 D and intolerance of glasses or contact lenses.

    • Document that the astigmatism is iatrogenic or surgically induced.
    • Do not submit an LRI solely to correct astigmatism that did not result from prior surgery.
    Denial Risk

    Ring Segments: Excluded Indications

    Intrastromal corneal ring segments are not medically indicated for individuals with mild myopia. Although they have been studied for post-LASIK corneal ectasia, long-term efficacy remains undetermined and post-LASIK ectasia is not an FDA-approved INTACS indication.

    • Limit submissions to the specified FDA-authorized INTACS indication for qualifying keratoconus.
    • Do not submit for mild myopia or post-LASIK ectasia.
    Denial Risk

    ALK Not Supported for Refractive Errors

    Automated lamellar keratoplasty (ALK), also called standard keratomileusis (CPT 65760), is unsupported for treatment of all refractive errors and is not medically necessary when performed solely for elective refractive treatment.

    • The AAO has reported only fair predictability and that ALK has largely been abandoned in favor of LASIK.
    • Consider the policy exclusion before submitting CPT 65760 for refractive correction.
    Denial Risk

    Conductive Keratoplasty Evidence Limitation

    Conductive keratoplasty (CPT 66999) is not medically necessary for elective treatment of presbyopia or other refractive errors because peer-reviewed evidence is insufficient to establish effectiveness and long-term refractive stability.

    • Published studies are limited primarily to small case series with short follow-up.
    • Professional guidance provides no strong recommendation supporting current clinical use.
    Denial Risk

    CAIRS Is Investigational

    Corneal allogenic intrastromal ring segments (CAIRS) remain investigational. Published peer-reviewed evidence is insufficient to establish long-term safety and efficacy for keratoconus or any other condition.

    • CAIRS is considered experimental, investigational, or unproven for any indication.
    • Reported short-term improvements do not establish sufficient long-term outcomes or safety.
    Refractive Error
    DefinitionA vision problem that occurs when the eye cannot focus light properly on the retina
    ExamplesMyopia, hyperopia, presbyopia, and astigmatism
    Astigmatism descriptionAn irregularly shaped cornea or lens
    Anterior Lamellar Keratoplasty
    ProcedureA partial-thickness corneal transplant
    Surgical actionA partial thickness of the cornea is removed
    ReplacementDiseased tissue is replaced with a partial-thickness donor cornea
    DALK
    Full nameDeep anterior lamellar keratoplasty
    UseUsed when pathology is confined to the front layers of the cornea
    Structures removedMost of the epithelium, Bowman's membrane, and stroma
    Arcuate Keratotomy
    Incision typeTransverse or arcuate paracentral corneal incisions
    PurposeAlter corneal curvature
    Clinical effectReduce or eliminate high-degree astigmatism
    Limbal Relaxing Incisions
    LocationFar peripheral aspect of the cornea
    PurposeReduce astigmatism
    UseMay be performed alone or combined with cataract extraction and intraocular lens implantation
    Intrastromal Corneal Ring Segments
    StructureFlexible ring segments inserted beneath the surface of the cornea
    MechanismElevate the edge of the cornea to flatten the front of the eye
    EffectDecrease nearsightedness
    Conductive Keratoplasty
    Energy sourceRadiofrequency thermal energy
    Treatment sitePeripheral corneal stroma
    Thermal range and effectApproximately 55°C-65°C, causing focal corneal shrinkage
    CAIRS
    TechniqueA corneal tissue-addition technique
    MaterialSemicircular segments of donor cornea
    Placement and effectSegments are inserted into intrastromal channels to produce effects similar to synthetic ring segments or corneal inlays
    Corneal Allogenic Intrastromal Ring Segments
    TissueSemicircular segments of donor corneal tissue
    Channel creationFemtosecond-laser-created intrastromal channels
    Additional treatmentCorneal collagen cross-linking may follow implantation
    Corneal Inlay
    StructureA thin disc-shaped corneal implant
    FeaturesMay have micro-perforations and no refractive power
    Purpose and placementPlaced through a pocket-shaped laser incision to increase depth of focus and improve near vision
    Corneal Tissue Addition Keratoplasty
    TechniqueA corneal tissue addition technique
    MaterialPreserved irradiated donor corneal tissue cut to individualized size specifications
    Placement and purposePlaced in a laser-created channel to reshape the cornea and improve vision
    Historical Elective Refractive Procedures
    CategoryOlder elective refractive procedures
    ExamplesHexagonal keratotomy, LASEK, laser thermokeratoplasty, minimally invasive radial keratotomy, and scleral expansion surgery
    Current statusNo longer in common use or largely abandoned
    Health Equity
    Health equityThe highest level of health for all people
    Health inequityAn avoidable difference in health status or distribution of health resources
    Underlying causeSocial conditions in which people are born, grow, live, work, and age
    Social Determinants of Health
    DefinitionConditions in the environment that affect a wide range of health, functioning, and quality-of-life outcomes and risks
    ExamplesSafe housing, transportation, neighborhoods, education, job opportunities, and income
    Additional factorsAccess to nutritious foods, clean air and water, and language and literacy skills